SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 72 filers reported holding SERES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,670,000 | -11.7% | 220,000 | 0.0% | 0.06% | -17.8% |
| Q2 2018 | $1,892,000 | +17.2% | 220,000 | 0.0% | 0.07% | +5.8% |
| Q1 2018 | $1,615,000 | -27.6% | 220,000 | 0.0% | 0.07% | -31.7% |
| Q4 2017 | $2,231,000 | -36.8% | 220,000 | 0.0% | 0.10% | -38.0% |
| Q3 2017 | $3,529,000 | +42.0% | 220,000 | 0.0% | 0.16% | +29.4% |
| Q2 2017 | $2,486,000 | +0.3% | 220,000 | 0.0% | 0.13% | -11.9% |
| Q1 2017 | $2,479,000 | +13.8% | 220,000 | 0.0% | 0.14% | -2.1% |
| Q4 2016 | $2,178,000 | -19.5% | 220,000 | 0.0% | 0.15% | -14.1% |
| Q3 2016 | $2,704,000 | -64.5% | 220,000 | -16.0% | 0.17% | -69.8% |
| Q2 2016 | $7,611,000 | +9.4% | 262,000 | 0.0% | 0.56% | -3.4% |
| Q1 2016 | $6,959,000 | -19.2% | 262,000 | +6.8% | 0.58% | -10.6% |
| Q4 2015 | $8,611,000 | +61.4% | 245,400 | +36.3% | 0.65% | +50.6% |
| Q3 2015 | $5,335,000 | -38.0% | 180,000 | -13.1% | 0.43% | -31.1% |
| Q2 2015 | $8,599,000 | – | 207,215 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |